Acute infectious purpura fulminans associated with asplenism or hyposplenism

Journal of the American Academy of Dermatology

Volumn 47, Issue 4, 2002, Pages 493-496

  Ward, Kimberley Morine ^a   Celebi, Julide Tok ^a   Gmyrek, Robyn ^a   Grossman, Marc E ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ANTIBODY RESPONSE; ARTICLE; ASPLENIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EARLY DIAGNOSIS; FEMALE; FULMINATING PURPURA; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; PRIORITY JOURNAL; SKIN NECROSIS;

EID: 0036787859     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124701     Document Type: Article

References (36)

1. Adcock DM, Bronza J, Marlar RA. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis. Semin Thromb Hemost 1990;16:333-40.
2. Adcock DM, Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemost 1990;16: 283-92.
3. Darmstadt, GL. Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998;15:169-83.
4. Lee PK, Weinberg AN, Swartz MN, Johnson RA. Bacterial diseases with cutaneous involvement. In: Freedberg IM, Eisen AZ, WolffK, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 2202.
5. Johansen K, Hansen ST. Symmetrical peripheral gangrene (purpura fulminans) complicating pneumococcal sepsis. Am J Surg 1993;165:642-5.
6. Francis RB. Acquired purpura fulminans. Semin Thromb Hemost 1990;16:310-25.
7. Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995;127:355-63.
8. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000;96:3719-24.
9. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-16.
10. Smith OP. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 1999;104:202-7.
11. Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol 1985;121: 1057-61.
12. Gamper G, Oschatz E, Herkner H, Paul G, Heinz B, Janata K, et al. Sepsis-associated purpura fulminans in adults. Wien Klin Wochenschr 2001;113:107-12.
13. Carpenter CT, Kaiser AB. Purpura fulminans in pneumococcal sepsis: case report and review. Scand J Infect Dis 1997;29:479-83.
14. Cnota JF, Barton LL, Rhee KH. Purpura fulminans associated with Streptococcus pneumoniae infection in a child. Pediatr Emerg Care 1999;15:187-8.
15. Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995;126:646-52.
16. Johansen K, Murphy T, Pavlin E, Ledbetter D. Digital ischemia complicating pneumococcal sepsis: reversal with sympathetic blockade. Crit Care Med 1991;19:114-5.
17. Rusonis PA, Robinson HN, Lamberg SI. Livedo reticularis and purpura: presenting features in fulminant pneumococcal septicemia in an asplenic patient. J Am Acad Dermatol 1986;15:1120-2.
18. Galanakis E, Apokotou M, Alfadaki S, Gesouli E, Lapatsanis P. Purpura fulminans complicating pneumococcal sepsis. EurJ Pediatr 1999;158:171.
19. Berrey MM, van Burik J. Symmetric peripheral gangrene. N Engl J Med 2001;344:1593.
20. Jackson RT, Luplow RE. Adult purpura fulminans and digital necrosis associated with sepsis and the factor V mutation. JAMA 1998;280:1829-30.
21. Hacking HG, Lo-a-Njoe BA, Visser-Meily JM. Multiple amputations due to sepsis: however, functional rehabilitation is possible. Ned Tijdschr Geneeskd 1999;143:1073-7.
22. Viaud JY, Allain P, Laurens E, Mazou JM, Lorre G, Poirier T. Pneumococcal meningoencephalitis associated with purpura fulminans in a nonsplenectomized subject. Presse Med 1990;19:1991-2.
23. Dhodapkar K, Corbacioglu S, Chang MW, Karpatkin M, DiMichele D. Purpura fulminans caused by group A β-hemolytic Streptococcus sepsis. J Pediatr 2000;137:562-7.
24. Sellers BJ, Woods ML, Morris SE, Saffle JR. Necrotizing group A streptococcal infections associated with streptococcal toxic shock syndrome. Am J Surg 1996;172:523-8.
25. Lloyd TR, Bolte RG. Rhinocerebral mucormycosis in an infant with streptococcal sepsis and purpura fulminans. Pediatr Infect Dis 1986;5:575-9.
26. Tambyah PA, Kumarasinghe G, Chan HL. Streptococcus suis infection complicated by purpura fulminans and rhabdomyolysis: case report and review. Clin Infect Dis 1997;24:710-2.
27. Kullberg BJ, Westendorp RGJ, van't Wout JW, Meinders AE. Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia-a complication of a dog bite. Medicine (Baltimore) 1991;70:287-92.
28. Chuansumrit A, Hotrakitya S, Kruavit A. Severe acquired neonatal purpura fulminans. Clin Pediatr (Phila) 1996;35:373-6.
29. Meier S, Zellwegger G, Elsner P, Wuthrich D, Krause M. Fulminant purpura in Still's disease and bacteremia with Xanthomonas maltophilia and coagulase-negative staphylococci. Schweiz Med Wochenschr 1994;124:900-5.
30. Kato N, Morioka T. Purpura fulminans secondary to Xanthomonas maltophilia sepsis in an adult with aplastic anemia. J Dermatol 1991;18:225-9.
31. Iten P, Stalder H, Vischer W. Symmetrical peripheral gangrene in disseminated tuberculosis. Dermatologica 1986;173:189-95.
32. Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection-an update. Crit Care Med 1999;27:836-42.
33. Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am 1996;10:693-707.
34. Holdsworth RJ, McKenzie H, Parratt D, Irving AD, Cuschieri A. The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria. Int J Exp Pathol 1990;71:835-43.
35. Holdrinet RSG. Postsplenectomy sepsis. Neth J Med 1988;32:298-302.
36. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 1990;88(5N):33N-42N.